Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Mendus

4.21 SEK

+1.45 %

Less than 1K followers

IMMU

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Mendus

2019202020212022202320242025
Revenue0.90.03.4
growth-%10,803.2 %
EBITDA-132.3-86.0-130.1-133.7-100.7-130.7-
EBIT-132.3-86.0-130.1-133.7-100.7-130.7-113.5
Profit before taxes-134.0-89.2-133.4-138.8-101.6-128.4-113.3
Net income-134.0-89.2-133.4-138.8-101.6-128.4-113.3
EPS-26.76-9.89-12.32-12.90-4.40-2.64-2.17
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-14,817.9 %-419,677.4 %-3,955.3 %
EBIT-%-14,817.9 %-419,677.4 %-3,955.3 %
ROE-49.1 %-13.5 %-20.3 %-27.0 %-14.4 %-19.9 %-19.4 %
ROI-44.1 %-12.2 %-18.5 %-22.4 %-13.4 %-18.4 %-18.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.